Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemicals products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed at research and development) is Bictegravir Na (IH).
Mangalam Drugs and Organics Ltd FAQs
How to Buy Mangalam Drugs and Organics Ltd Share?
To purchase Mangalam Drugs and Organics Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Mangalam Drugs and Organics Ltd (ticker symbol: MANGALAM) on the trading platform provided by your broker and purchase the shares.
What's Mangalam Drugs and Organics Ltd share price today?
The stock price of Mangalam Drugs and Organics Ltd as of 07 Oct 2025 is ₹70.26
What is the Market Cap of Mangalam Drugs and Organics Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Mangalam Drugs and Organics Ltd (ticker symbol: MANGALAM) has a market capitalisation of approximately ₹1,20,00,00,000.00
What is the PE and PB ratio of Mangalam Drugs and Organics Ltd?
Mangalam Drugs and Organics Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 0.78, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 16.53, indicating the market values the company at around ₹16.53 for every ₹1 of earnings
What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd Share?
Mangalam Drugs and Organics Ltd Ltd (MANGALAM) hit its 52-week high at ₹128.01, and its 52-week low at ₹68.82.